Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100049082Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in postoperative pain (3 arms), sponsored by Shanghai Zhongye Hospital. Primary endpoints: Pain score and PCA times. Planned start Jun 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100049082.